A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma.

Morris, D L

A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma. [electronic resource] - Cancer May 1996 - 1956-7 p. digital

Publication Type: Comment; Letter

0008-543X

10.1002/(SICI)1097-0142(19960501)77:9<1956::AID-CNCR29>3.0.CO;2-Y doi


Antineoplastic Agents, Hormonal--administration & dosage
Carcinoma--drug therapy
Clinical Trials, Phase III as Topic
Colonic Neoplasms--drug therapy
Hormone Antagonists--administration & dosage
Humans
Neoplasm Staging
Octreotide--administration & dosage
Rectal Neoplasms--drug therapy
Somatostatin--administration & dosage
Survival Rate